Apollo Hospitals, has partnered with RMS REGROW, the first ‘Make in India’ Company in Cell Therapy Technology, to offer two new Regenerative Medicine Cell Therapy products – Ossron and Chondron for bone and cartilage problems, respectively. The two products will address unmet clinical needs in the orthopaedic market with respect to sports injuries, accidents and alternate to hip replacements and knee replacements for a young arthritic knee.
In an exclusive tie up between Apollo Hospitals and RMS Regrow, the treatment therapy will be made available across all Apollo Hospitals, Apollo Spectra Hospitals and Apollo clinics in India. Ossron and Chondron are the results of a dedicated research team at REGROW. The two products are innovative proprietary and patented technology which has been developed for both the products following the regulatory guidelines.
Through several clinical trials and evaluation studies over 8 years, the company has achieved the market authorization for the two cell therapy products. As an exclusive offering, Apollo Hospitals will create a platform for orthopaedic doctors to practice Regenerative Medicine efficiently by conducting live surgical workshops, CME’s for doctors and conferences (national and international).
Title
Partnership for cell therapy treatment
VATIS UPDATE Part
Article body
Source